Literature DB >> 4626581

Direct immunoassay of triiodothyronine in human serum.

P R Larsen.   

Abstract

A sensitive and precise radioimmunoassay for the direct measurement of triiodothyronine (T(3)) in human serum has been designed using sodium salicylate to block T(3)-TBG binding. This assay is sufficiently sensitive to quantitate T(3) accurately in 50-100 mul of normal serum and to measure quantities as small as 12.5 pg in 0.2 ml of hypothyroid serum. The T(3) values observed in euthyroid subjects and in patients with various thyroid diseases are as follows: euthyroid (38) 1.10+/-0.25 (SD) ng/ml, hypothyroid (25) 0.39+/-0.21 (SD) ng/ml, and hyperthyroid (24) 5.46+/-4.42 (SD) ng/ml. The levels of T(3) parallel the thyroxine (T(4)) concentration in the sera of these subjects. In eight pregnant women at the time of delivery, T(3) concentrations were in the upper normal range (mean 1.33 ng/ml). The levels of T(3) in cord serum obtained at the time of delivery of these patients (mean 0.53 ng/ml) are distinctly lower and close to the hypothyroid mean. Administration of 10 U of bovine thyroid-stimulating hormone (TSH) to euthyroid subjects causes a two-fold increase in serum T(3) levels within 8 hr. At this time, the increase in serum T(4) concentration is only 41%. In two subjects in whom thyroid secretion was acutely inhibited, one after pituitary surgery and another after thyroidectomy, the serum T(3) fell into the hypothyroid range within 1-2 days. Thus, serum T(3) concentrations appear to be a sensitive index of acute changes in thyroid hormone secretion and should prove to be a useful adjunct to both the clinical and physiological evaluation of thyroid function.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4626581      PMCID: PMC292350          DOI: 10.1172/JCI107000

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Adaptation of the standard Durrum-type cell for reverse-flow paper electrophoresis.

Authors:  K E ELZINGA; E A CARR; W H BEIERWALTES
Journal:  Am J Clin Pathol       Date:  1961-08       Impact factor: 2.493

2.  The identification of 3:5:3'-L-triiodothyronine in human plasma.

Authors:  J GROSS; R PITT-RIVERS
Journal:  Lancet       Date:  1952-03-01       Impact factor: 79.321

3.  Production of antibodies specifically binding triiodothyronine and thyroxine.

Authors:  I J Chopra; J C Nelson; D H Solomon; G N Beall
Journal:  J Clin Endocrinol Metab       Date:  1971-03       Impact factor: 5.958

4.  Specific antibodies to triiodothyronine hormone.

Authors:  B L Brown; R P Ekins; S M Ellis; W S Reith
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

5.  Technical aspects of the estimation of triiodothyronine in human serum: evidence of conversion of thyroxine to triiodothyronine during assay.

Authors:  P R Larsen
Journal:  Metabolism       Date:  1971-06       Impact factor: 8.694

6.  Radioimmunoassay of triiodothyronine in unextracted human serum.

Authors:  T Mitsuma; M Gershengorn; J Colucci; C S Hollander
Journal:  J Clin Endocrinol Metab       Date:  1971-08       Impact factor: 5.958

7.  Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects.

Authors:  L E Braverman; S H Ingbar; K Sterling
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

8.  Total and free triiodothyronine in human serum.

Authors:  J A Nauman; A Nauman; S C Werner
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

9.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

10.  The measurement of digitoxin in human serum by radioimmunoassay.

Authors:  G C Oliver; B M Parker; D L Brasfield; C W Parker
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more
  32 in total

1.  The radioimmunoassay of triiodothyronine and its clinical application.

Authors:  C J Eastman; J M Corcoran; R P Ekins; E S Williams; J D Nabarro
Journal:  J Clin Pathol       Date:  1975-03       Impact factor: 3.411

2.  Serum tri-iodothyronine, thyroxine, and thyrotrophin concentrations in newborns during the first 2 days of life.

Authors:  S Similä; M Koivisto; T Ranta; J Leppäluoto; M Reinilä; J Haapalahti
Journal:  Arch Dis Child       Date:  1975-07       Impact factor: 3.791

3.  Comparative study of pituitary-thyroid hormone economy in fasting and hypothyroid rats.

Authors:  D L St Germain; V A Galton
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  The occurrence of T3 thyrotoxicosis in pregancy.

Authors:  D H Martin; D A Montgomery; J M Harley
Journal:  Ir J Med Sci       Date:  1976-12       Impact factor: 1.568

5.  Plasma triiodothyronine at the end of pregnancy, in the cord blood and in the first days of the newborn.

Authors:  M Hüfner; R D Hesch; U Heinrich; D Lüders
Journal:  Z Kinderheilkd       Date:  1973

6.  Radioimmunoassay of triiodothyronine in unextracted human serum.

Authors:  R D Hesch; D Evered
Journal:  Br Med J       Date:  1973-03-17

7.  3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man.

Authors:  L A Gavin; M E Hammond; J N Castle; R R Cavalieri
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

8.  Triiodothyronine and thyroxine in the serum and thyroid glands of iodine-deficient rats.

Authors:  G M Abrams; P R Larsen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

9.  Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.

Authors:  J Abuid; P R Larsen
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

10.  A new radioimmunoassay for plasma L-triiodothyronine: measurements in thyroid disease and in patients maintained on hormonal replacement.

Authors:  M I Surks; A R Schadlow; J H Oppenheimer
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.